Site Search
Search Results
Virtual Policy Forum to Highlight the Role of Research in Equitable Access to High-Quality Cancer Care in California
Sacramento, Calif . – A panel of experts in cancer care and equity will participate in a panel discussion on the critical need for research that addresses tangible, impactful solutions for equitable ... said Kay Coleman, chair of the ACS CAN California Leadership Council and state lead ambassador for ACS CAN. The 2022 ACS CAN California Virtual Health and Equity Policy Forum will bring together experts whose work is key to address gaps in cancer prevention and care delivery, reduce cancer ... cancer researcher and current chair of the National Cancer Advisory Board, will deliver a keynote speech on closing the gaps in cancer health. Dr. Robert A. Winn , director of Virginia Commonwealth University Massey Cancer Center will moderate the panel discussion. Panel members ...
Research to Reality: Dismantling Disparities in Cancer Care
***Pre-Registration has now closed. You may register day of the event at acscan.windrosemedia.com .*** 2022 California Research and Health Equity Policy Forum The American Cancer Society Cancer Action Network (ACS CAN) is the nation's leading advocacy organization working ... to make issues facing cancer patients a national and state priority. Donate or Support Advancing Research, Innovation and Health Equity Join us for the ACS CAN California Research & Health Equity Forum , held virtually on August 10th, which will focus on challenges ... and the private sector are rising to the challenge to address many of these disparities, and how public policies can ensure that advances in care are accessible for all communities. Program includes: Research to Reality: Dismantling Disparities in Cancer Care will feature Keynote ...
California Assembly Committee Passes Legislation Requiring More Insurance Plans Cover Biomarker Testing Needed for Many Innovative Cancer Treatments
Sacramento, Calif. – June 21, 2022 – The California Assembly Health Committee passed a bill today that would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when ... mutations – which can be measured in blood, tissue or other biospecimens. “Despite its benefits and increasingly important role in cancer care and improving cancer outcomes, 66% of oncology providers reported that insurance coverage is a significant or moderate barrier to appropriate ... the American Cancer Society Cancer Action Network (ACS CAN). “It’s imperative we dismantle cost barriers in order to address and help reduce health disparities.” Communities that have been under-resourced, including communities of color, individuals with limited income, rural residents ...
Cancer Advocates Urge California Governor to Sign Legislation Expanding Access to Biomarker Testing Needed for Many Innovative Treatments
Sacramento, Calif. – The California Legislature passed a bill last night that would ensure comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Senate Bill 912 – which was introduced by Senator ... that have been under-resourced, including communities of color, individuals with limited income, rural residents and patients receiving care in non-academic medical centers are less likely to receive recommended biomarker testing. “The advances in cancer treatment that have come ... from being able to tailor approaches to a person’s individual condition are critical for winning the fight against cancer and helping reduce health disparities,” said Carrie L. Byington, M.D., executive vice president of University of California Health. “California has the ...
David Ford Named to American Cancer Society Cancer Action Network’s National Board of Directors
... and guidance for ACS CAN, which pursues evidence-based public policy and legislative solutions designed to eliminate cancer as a major health problem nationwide. His term begins on Jan. 1, 2022. “ACS CAN is exceedingly fortunate to have a volunteer leader as dedicated and ... served in the American Cancer Society’s Board of Directors for the Los Angeles area and has championed local and national efforts to advance health equity. As an ACS volunteer, he recently partnered with L.A. Care Health Plan to promote regular cancer screenings, especially among communities of color. “As a cancer survivor and advocate, I’m committed ...
Cancer Research Through A Health Equity Lens
... event will feature presentations from cancer researchers on cutting-edge science at the forefront of breakthroughs in diagnosis, treatment, care, and survivorship coupled with policy proposals that ensure these advancements are available for all. Research is the fuel for progress in cancer and the investment in research needs to be strong and sustained to realize that progress for ALL. Experts in cancer research and health equity will share inspiring stories of the power of research and will highlight exciting developments, followed by a moderated panel to ... Congressional Hispanic Caucus Moderated by: David Tom Cooke, MD, FACS, Professor and Chief, Division of General Thoracic Surgery at UC Davis Health Support Our Mission - Donate While there is no fee to participate, donations are welcomed and can be made here . Special Thank ...
State Senate Committee Votes to Increase Access to Innovative Testing and Lifesaving Treatments
Video with cancer survivor’s story here . Sacramento, Calif. – The California Senate Health Committee voted Wednesday evening to advance a bill that would increase access to biomarker testing, a critical step in accessing precision ... that have been under-resourced, including communities of color, individuals with limited income, rural residents and patients receiving care in non-academic medical centers are less likely to receive recommended biomarker testing. “We urge the legislature to pass this bill to help ... California Legislative Director for ACS CAN. “Improving coverage for and access to biomarker testing across insurance types is key to reducing health inequities and improving cancer outcomes.” For more information on precision medicine, cancer biomarkers, current barriers to biomarker ...